Australia vs Bolivia, Plurinational State of: Hepatitis B surface antigen (HBsAg) prevalence
Australia
0.1%
in 2024
Bolivia, Plurinational State of
0.1%
in 2024
Australia rank
101st
Bolivia, Plurinational State of rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Australia
- Bolivia, Plurinational State of
How they compare
Australia currently reports 0.1% against 0.1% in Bolivia, Plurinational State of, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Bolivia, Plurinational State of ahead.
Australia ranks 101st and Bolivia, Plurinational State of ranks 101st of 194 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Bolivia, Plurinational State of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.0% | 0.1% | Australia |
| 2020s | 0.1% | 0.1% | 0.0% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Australia or Bolivia, Plurinational State of?
- Australia, at 0.1% against 0.1% in Bolivia, Plurinational State of as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Australia and Bolivia, Plurinational State of?
- 0.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Bolivia, Plurinational State of?
- 10 years are reported by both, from 2015 to 2024.
- How do Australia and Bolivia, Plurinational State of rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Australia ranks 101st and Bolivia, Plurinational State of ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.